Telepharmacy on Patients With Arterial Hypertension
ConditionHypertension
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60+
SponsorFederal University of Bahia
About this trial
The goal of this clinical trial is to compare the effectiveness of a pharmaceutical care protocol via teleconsultation in the management of uncontrolled hypertension with pharmaceutical care carried out in elderly patients assisted in primary health care. The main questions it aims to answer are:
1. How effective is a pharmaceutical care protocol via teleconsultation on the clinical outcomes of elderly people with uncontrolled hypertension, when compared to in-person pharmaceutical care? 2. How effective is a pharmaceutical care protocol via teleconsultation in adherence to the treatment of elderly people with hypertension, when compared to in-person pharmaceutical care?
Participants will undergo four visits. Two visits will be for the application of instruments and measurement of clinical parameters to be carried out at the beginning and end of follow-up (visits 1 and 4). These will be carried out in a pharmacist's office at the pharmacy by previously trained pharmacists and pharmacy students. Visits 2 and 3 will be pharmaceutical consultations to be carried out in person and/or via telepharmacy.
Researchers will compare pharmaceutical care via telepharmacy with in-person pharmaceutical care to see how effective these services are in controlling blood pressure in elderly patients with uncontrolled blood pressure.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Elderly patients admitted to the service with a diagnosis of systemic arterial hypertension made by a physician based on a patient report, report or medical prescription.
Patients who present uncontrolled blood pressure at the time of assessment based on the average of three measurements using a standardized protocol at the pharmacy will be included;
Patients must have a cell phone and know how to use it;
Patient not have previously received pharmaceutical care.
Disqualifiers
Elderly people who are unable to use their cell phones due to cognitive impairments (Mini Mental State Examination (MMSE).
Elderly person considered unable of using a telephone (Instrumental Activities of Daily Living)
Elderly with controlled blood pressure according to home monitoring.
Trial design
Design model
Parallel
Treatments tested in this trial
Pharmaceutical care via telepharmacy and usual care
Other interventionPharmacotherapeutic monitoring via telephone consultation
Pharmaceutical care in-person and usual care
Other interventionFace-to-face pharmacotherapeutic monitoring
Treatment groups
194 Participants
are divided into 2 treatment groupsGroup A: TelepharmacyExperimental treatment 1 intervention
Group B: In-personActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Controlling blood pressure
Rate of patients reaching the blood pressure target for healthy elderly people: systolic pressure of 130-139 mmHg and diastolic pressure of 70-79 mmHg; and for frail elderly people: systolic pressure of 140-149 mmHg and diastolic pressure of 70-79mmHg according to guidelines from the Brazilian Society of Cardiology of 2020
Time frame
3 monthsSecondary outcomes
1
Adherence to the treatment
Patients who score higher than eight points on the adherence scale will be considered to have high adherence, those who score between six and seven points will be classified as medium adherence and those who score less than 6 points will be classified as low adherence.
Time frame
3 months2
Patient satisfaction
The score will be calculated by the sum of the user's answers divided by the number of corresponding questions. Thus, the closer to 5, the greater the satisfaction with the service and the closer to 1, the greater the dissatisfaction.
Time frame
3 months3
Level of clinical significance of interventions
Clinical significance of the intervention as described by the DOCUMENT, which classifies interventions into four levels of clinical significance: low; light; moderate and high.
Time frame
3 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov